Author

E. Newell

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Organism:human· 5 Research Focus:cell type annotation· 4 Research Focus:cell signaling & trafficking· 3 Assay:flow cytometry· 3 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

S. Li· 2 shared A. F. George· 1 shared A. Larbi· 1 shared A. Lee· 1 shared A. Saxena· 1 shared A. Singhal· 1 shared A. Tizazu· 1 shared A. Todd· 1 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

S. Li

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

MR1-restricted T cell clonotypes are associated with 'resistance' to M.tuberculosis infection

D. L. Cross, E. D. Layton, K. K. Yu, M. T. Smith, M. S. Aguilar, S. Li, H. Mayanja-Kizza, C. M. Stein, W. H. Boom, T. R. Hawn, P. Bradley, E. Newell, C. Seshadri

The paper identifies MR1-restricted T cell clonotypes associated with resistance to M. tuberculosis infection in a cohort of Ugandan individuals.

bioRxiv · Oct 12, 2022 · PreprintImmunology

Protracted yet coordinated differentiation of long-lived SARS-CoV-2-specific CD8+ T cells during COVID-19 convalescence

T. Ma, H. Ryu, M. McGregor, B. Babcock, J. Neidleman, G. Xie, A. F. George, J. Frouard, V. Murray, G. Gill, E. Ghosn, E. Newell, S. Lee, N. Roan

The paper characterizes the long-term differentiation of SARS-CoV-2-specific CD8+ T cells in convalescent donors, showing coordinated evolution with other immune components over six months.

bioRxiv · Apr 28, 2021Immunology

Metformin enhances anti-mycobacterial responses by educating immunometabolic circuits of CD8+ T cells

J. Bohme, N. Martinez, S. Li, A. Lee, M. Marzuki, A. Tizazu, D. Ackart, J. Frenkel, A. Todd, E. Lachmandas, J. Lum, F. Shihui, T. P. Ng, B. Lee, A. Larbi, , A. Singhal

This study shows metformin improves anti-mycobacterial responses by enhancing metabolic and functional properties of CD8+ T cells in mice and humans.

bioRxiv · Aug 26, 2020Immunology

Engineered niches support the development of human dendritic cells in humanized mice

G. Anselmi, K. Vaivode, C.-A. Dutertre, P. Bourdely, Y. Missolo-Koussou, E. Newell, O. Hickman, K. Wood, A. Saxena, J. Helft, F. Ginhoux, P. Guermonprez

This study shows engineered mesenchymal stromal cells can generate human dendritic cells in vivo, closely resembling blood-derived cDCs.

bioRxiv · Nov 8, 2019Immunology

CD38 is a good predictor of anti-PD-1 immunotherapy responsiveness in hepatocellular carcinoma

S. Goh, H. H. M. Ng, V. Chew, X. N. Sim, H. Li, S. Lim, J. C. T. Lim, J. J. H. Loh, K. Sabai, C. C. H. Ong, T. Loh, W. Q. Leow, J. J. X. Lee, H. C. Toh, F. Malavasi, , T. K. H. Lim

The paper shows CD38 expression in immune infiltrates predicts response to anti-PD-1 immunotherapy in HCC patients.

bioRxiv · May 15, 2019 · PreprintCancer Biology